In non-small cell lung cancer (NSCLC), elevated TIL-PC levels correlate with prolonged overall survival in anti-PD-L1-treated patients, a phenomenon associated with lymphoid aggregation and tertiary lymphoid structure (TLS) formation (143). This evidence concerns the gene CD274 and non-small cell lung carcinoma.